Kawakita, E., Koya, D., & Kanasaki, K. (2021). CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology. Cancers (Basel).
استشهاد بنمط شيكاغوKawakita, Emi, Daisuke Koya, و Keizo Kanasaki. "CD26/DPP-4: Type 2 Diabetes Drug Target With Potential Influence On Cancer Biology." Cancers (Basel) 2021.
MLA استشهادKawakita, Emi, Daisuke Koya, و Keizo Kanasaki. "CD26/DPP-4: Type 2 Diabetes Drug Target With Potential Influence On Cancer Biology." Cancers (Basel) 2021.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.